Abstract:The study aimed to confirm the association between some single nucleotide polymorphisms (SNPs) and metabolic dysfunction‐associated fatty liver disease (MAFLD) in western China. We found no association between these SNPs and the risk of MAFLD after Benjamini‐Hochberg adjustment. PNPLA3 rs738409 was associated with the AST levels in MAFLD patients. GCKR variants were associated with increased triglycerides levels and reduced serum fasting glucose in patients with MAFLD. In addition, there was no synergistic SNP–SNP interaction between PNPLA3 rs738409 and other SNPs on MAFLD. Introduction We aimed to confirm the association between some single nucleotide polymorphisms (SNPs) and metabolic dysfunction‐associated fatty liver disease (MAFLD) in western China. Methods A total of 286 cases and 250 healthy controls were enrolled in our study. All samples were genotyped for patatin‐like phospholipase domain containing 3 (PNPLA3) rs738409, transmembrane 6 superfamily member 2 (TM6SF2) rs58542926, membrane‐bound O‐acyltransferase domain containing 7 (MBOAT7) rs641738, glucokinase regulator (GCKR) rs1260326 and rs780094, and GATA zinc finger domain containing 2A (GATAD2A) rs4808199. Using logistic regression analysis, we evaluated the association between MAFLD and each SNP under different models. Multiple linear regression was used to find the association between SNPs and laboratory characteristics. Multifactor dimensionality reduction was applied to test SNP–SNP interactions. Results The recessive model and additive model of PNPLA3 rs738409 variant were related to MAFLD (odds ratio [OR] = 1.791 and 1.377, respectively, p = 0.038 and 0.027, respectively). However, after Benjamini‐Hochberg adjustment for multiple tests, all associations were no longer statistically significant. PNPLA3 rs738409 correlated with AST levels. GCKR rs780094 and rs1260326 negatively correlated with serum glucose but positively correlated with triglycerides in MAFLD. Based on MDR analysis, the best single‐locus and multilocus models for MAFLD risk were rs738409 and six‐locus models, respectively. Conclusions In the Han population in western China, no association was found between these SNPs and the risk of MAFLD. PNPLA3 rs738409 was associated with aspartate aminotransferase levels in MAFLD patients. GCKR variants were associated with increased triglyceride levels and reduced serum fasting glucose in patients with MAFLD.

PNPLA3 Genotype and Dietary Fat Modify Concentrations of Plasma and Fecal Short Chain Fatty Acids and Plasma Branched-Chain Amino Acids

I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders

The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes

The rs2294918 E434K variant modulates PNPLA3 expression and liver damage.

Genetic Variation in PNPLA3 Confers Susceptibility to Nonalcoholic Fatty Liver Disease

A Single Nucleotide Polymorphism in the FADS1 Gene is Associated with Plasma Fatty Acid and Lipid Profiles and Might Explain Gender Difference in Body Fat Distribution

The PNPLA3 Rs738409 C>G Variant Influences the Association Between Low Skeletal Muscle Mass and NAFLD: the Shanghai Changfeng Study

Polyunsaturated Fatty Acids (PUFA) Modulate Association Between PIK3CA‐KCNMB3 Variants and Insulin Resistance

Genetic Variants at PSMD3 Interact with Dietary Fat and Carbohydrate to Modulate Insulin Resistance

Polyunsaturated Fatty Acids Modulate the Association Between PIK3CA-KCNMB3 Genetic Variants and Insulin Resistance

Genetic Variant I148M in PNPLA3 is Associated with the Ultrasonography-Determined Steatosis Degree in a Chinese Population.

A Val227Ala Substitution in the Peroxisome Proliferator Activated Receptor Alpha (PPAR Alpha) Gene Associated with Non‐alcoholic Fatty Liver Disease and Decreased Waist Circumference and Waist‐to‐hip Ratio

A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease

The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats

Abstract 13791: Non-Alcoholic Fatty Liver Disease Risk SNP Variants Affect Lipid Metabolism

Evaluation of Leptin Receptor Lys109Arg Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease

Genetic variants associated with metabolic dysfunction‐associated fatty liver disease in western China

Pro12Ala Substitution in the Peroxisome Proliferator-Activated Receptor Gamma (pparγ) Gene and Non-Alcoholic Fatty Liver Disease

PNPLA3 I148M Variant Affects Non-Alcoholic Fatty Liver Disease in Liver Transplant Recipients

Modification in mitochondrial function is associated with the FADS1 variant and its interaction with alpha-linolenic acid-enriched diet - an exploratory study

High red meat consumption among PNPLA3 polymorphism carriers is associated with NAFLD in a multi-center cross-sectional study